AIT Therapeutics Inc Share Price Other OTC
Equities
US50027L1070
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
30/04 | Truist Lowers Price Target on Beyond Air to $8 From $10, Keeps Buy Rating | MT |
12/02 | Beyond Air, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Sales 2024 * | 1.44M 120M | Sales 2025 * | 13.2M 1.1B | Capitalization | 58.75M 4.9B |
---|---|---|---|---|---|
Net income 2024 * | -62M -5.17B | Net income 2025 * | -64M -5.34B | EV / Sales 2024 * | 32.4 x |
Net cash position 2024 * | 12.15M 1.01B | Net Debt 2025 * | 2.95M 246M | EV / Sales 2025 * | 4.68 x |
P/E ratio 2024 * |
-0.66
x | P/E ratio 2025 * |
-0.73
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.02% |
Latest transcript on AIT Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 13/17/13 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 01/21/01 |
Amir Avniel
PSD | President | 50 | 13/17/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 01/15/01 |
William Forbes
BRD | Director/Board Member | 62 | 13/18/13 |
Erick Lucera
BRD | Director/Board Member | 57 | 10/17/10 |
1st Jan change | Capi. | |
---|---|---|
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |